Biography for Dr. Ganesh Raj

Ganesh Raj, M.D., Ph.D., is an Associate Professor of Urology at UT Southwestern Medical Center and the Director of the urologic oncology fellowship program.

Dr. Raj joined the faculty in 2006 after completing his urology training at Duke University Medical Center and his urologic oncology fellowship at Memorial Sloan-Kettering Cancer Center in New York.

Dr. Raj specializes in urologic oncology, including the treatment of high-risk prostate, bladder, kidney, and testis cancers. He is one of the leading urologic cancer surgeons in the country, with superb outcomes using open, laparoscopic, and robotic techniques. He has particular expertise in nerve-sparing techniques and in complex salvage procedures.

His clinical interests include optimizing oncologic and surgical outcomes for patients with urologic cancers using minimally invasive and multimodality approaches.

Dr. Raj has been recognized as one of “America’s Best Doctors” and has received both the Patient’s Choice Award as one of Texas’ top physicians and the Compassionate Doctor Recognition Award.

Dr. Raj is a national research and thought leader in prostate cancer. His basic science research is focused on the identification and targeting of molecular drivers of carcinogenesis in innovative clinical model systems. In prostate cancer, his research team has identified critical drivers of advanced prostate cancer and developed novel small molecule therapeutic agents – peptidomimetics – against these drivers. His cutting-edge research program has received funding from the Prostate Cancer Foundation, the Department of Defense, private foundations, and pharmaceutical companies.

He has authored more than 75 publications in high-impact, peer-reviewed journals such as the Journal of Clinical Oncology, Lancet Oncology, Cancer, and Molecular and Cellular Biology.

Dr. Raj has received numerous honors for his work throughout his career, including first prize from the American Urological Association for his laboratory research on prostate cancer. He serves as a peer reviewer for many significant peer-reviewed journals in basic science, urology, and oncology and is frequently invited to speak at universities and national conferences.

Professional Associations & Affiliations

  • American Urologic Association
  • Society of Urologic Oncology

Honors and Awards

    Visiting Lectureship, Adelaide Australia (2014)
    Awarded to the top-rated abstract in steroid signaling (2010)
    Awarded to the top-rated abstract in genitourinary oncology (2008)
  • ASCO Foundation Merit Award
    Awarded to the top-rated abstracts in prostate cancer, Prostate Cancer Symposium, San Francisco, CA (2006)
  • Society of Memorial Sloan Kettering Research Award
    Awarded for perineural therapeutics and cavernous nerve injury, Society of Memorial Sloan Kettering (2005)
  • AUA/Praecis Gerald P. Murphy Scholar
    Distinction in the study of prostate cancer, AUA Annual Meeting, Orlando FL (2002)
  • AUA Circon Basic Science Research Award (1st Place)
    Laboratory research/ AUA Annual Meeting, Anaheim, CA (2001)
  • Sigma Xi Research Award (1st Place)
    Most outstanding basic science research of the year, Philadelphia Chapter, Sigma Xi Research Society, Philadelphia, PA (1994)